We conducted a retrospective observational cohort study including 45 consecutive patients with AAV diagnosed between 2000 and 2014 with serum C3 measurement at diagnosis, before immunosuppressive treatment initiation. This evidence concerns the gene C3 and anti-neutrophil cytoplasmic antibody-associated vasculitis.